Reuters logo
BRIEF-Ionis Pharmaceuticals says earned $5 mln milestone payment from Janssen Biotech
December 22, 2016 / 12:28 PM / 9 months ago

BRIEF-Ionis Pharmaceuticals says earned $5 mln milestone payment from Janssen Biotech

Dec 22 (Reuters) - Ionis Pharmaceuticals Inc

* Ionis Pharmaceuticals earns milestone payment from Janssen for advancing a new program under GI collaboration

* Ionis Pharmaceuticals - earned $5 million milestone payment from Janssen Biotech associated with validation of undisclosed target to treat patients with gastrointestinal autoimmune disease

* Ionis Pharmaceuticals - under collaboration, Ionis,Janssen will continue to evaluate target with goal of advancing an antisense drug into development

* Ionis Pharma -under terms of agreement, co is eligible to receive nearly $800 million in development, regulatory, sales milestone payments, license fees

* Ionis Pharmaceuticals Inc - will receive tiered royalties that on average are double-digits on sales from any product that is commercialized Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below